ARCHIVES

Preoperative Drug Combo Benefits HER-2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

ACS Offers New Grants to Physicians

September 7, 1984

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

National Cancer Act: Early Promises Were Overstated

May 15, 1998

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

Community Clinical Oncology Program Renewed, NCI Hopes To Restore Cuts In ’08.

March 30, 2007